1251570-77-0Relevant articles and documents
Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor
Dreyfus, Nicolas,Myers, Jason K.,Badescu, Valentina O.,De Frutos, Oscar,De La Puente, Maria Luz,Ding, Chunjin,Filla, Sandra A.,Fynboe, Karsten,Gernert, Douglas L.,Heinz, Beverly A.,Hemrick-Luecke, Susan K.,Johnson, Kirk W.,Johnson, Michael P.,Lopez, Pilar,Love, Patrick L.,Martin, Laura J.,Masquelin, Thierry,McCoy, Michael J.,Mendiola, Javier,Morrow, Denise,Muhlhauser, Mark,Pascual, Gustavo,Perun, Thomas J.,Pfeifer, Lance A.,Phebus, Lee A.,Richards, Simon J.,Rincon, Juan Antonio,Seest, Eric P.,Shah, Jikesh,Shaojuan, Jia,Simmons, Rosa Maria A.,Stephenson, Gregory A.,Tromiczak, Eric G.,Thompson, Linda K.,Walter, Magnus W.,Weber, Wayne W.,Zarrinmayeh, Hamideh,Thomas, Craig E.,Joshi, Elizabeth,Iyengar, Smriti,Johansson, Anette M.
, p. 560 - 564 (2013/07/26)
The objective of the described research effort was to identify a novel serotonin and norepinephrine reuptake inhibitor (SNRI) with improved norepinephrine transporter activity and acceptable metabolic stability and exhibiting minimal drug-drug interaction. We describe herein the discovery of a series of 3-substituted pyrrolidines, exemplified by compound 1. Compound 1 is a selective SNRI in vitro and in vivo, has favorable ADME properties, and retains inhibitory activity in the formalin model of pain behavior. Compound 1 thus represents a potential new probe to explore utility of SNRIs in central nervous system disorders, including chronic pain conditions.
SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR
-
Page/Page column 5-6, (2010/11/03)
A serotonin and norepinephrine reuptake inhibitor of the formula: its uses, and methods for its preparation are described.